# A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

> **NCT07573176** · PHASE3 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 600 (estimated)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Seltorexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07573176
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2028-08-24
- **Final completion:** 2029-05-03
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07573176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07573176, "A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07573176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*